Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
8.62
-0.87 (-9.17%)
At close: Jun 8, 2026, 4:00 PM EDT
8.72
+0.10 (1.16%)
After-hours: Jun 8, 2026, 7:59 PM EDT
Novavax Employees
Novavax had 749 employees as of December 31, 2025. The number of employees decreased by 203 or -21.32% compared to the previous year.
Employees
749
Change (1Y)
-203
Growth (1Y)
-21.32%
Revenue / Employee
$796,179
Profits / Employee
-$117,270
Market Cap
1.42B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Ascentage Pharma Group International | 767 |
| Nurix Therapeutics | 317 |
| Syndax Pharmaceuticals | 298 |
| Biohaven | 274 |
| Capricor Therapeutics | 231 |
| Taysha Gene Therapies | 99 |
| Tyra Biosciences | 87 |
NVAX News
- 4 days ago - Novavax Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 7 days ago - Novavax to Participate in 2026 Jefferies Global Healthcare Conference - PRNewsWire
- 26 days ago - Novavax Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 27 days ago - Novavax Slides: Corporate presentation - Filings
- 4 weeks ago - Hantavirus cases spark surge in pharma and biotech stocks — here's why - CNBC
- 4 weeks ago - Novavax to Participate in BofA Securities 2026 Health Care Conference - PRNewsWire
- 4 weeks ago - Novavax reports Q1 EPS (6c), consensus (23c) - TheFly
- 4 weeks ago - Novavax price target raised to $9 from $8 at TD Cowen - TheFly